Skip to main content

Funding for Global Research and Training

The Center for Global Health helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.

Explore a full listing of NIH funding announcements.

Current Funding Opportunities

Learn more about current international cancer research and cancer control funding opportunities developed by CGH, or supported by NCI in collaboration with other NIH Institutes and Centers or research organizations.

2020 Stigma Research Training Institute

Call for Applications
The National Cancer Institute, in collaboration with Fogarty International Center and our NIH partners, is hosting a short-term Stigma Research Training Institute on June 8-11, 2020 in Bethesda, MD. The Institute is intended to promote transdisciplinary and novel health-related stigma research methods to a cohort of researchers from diverse fields to strengthen research capacity in this area. Eligible applicants may submit proposals to CRDF Global through February 10, 2020.

Notice of Intent to Publish: Strengthening Institutional Capacity to Conduct Global Cancer Research (D43)

The National Cancer Institute intends to publish the Strengthening Institutional Capacity to Conduct Global Cancer Research (D43) funding opportunity announcement (FOA) as a request for applications that will invite applications from U.S.-based cancer-research intensive institutions who propose research training programs working in collaboration with a low-and middle-income country institution to strengthen capacity to conduct global research. The overarching goal of this research training program is to provide investigators and health professionals with the scientific expertise, mentorship, and leadership skills needed to conduct innovative and collaborative global research projects that will contribute to the advancement of basic, clinical, translational, and population-based cancer research. This FOA is expected to be published in the NIH Guide in the winter of 2020, with expected application due dates in spring 2020 and winter 2021.

Microbial-based Cancer Therapy - Bugs as Drugs (R01/R21)

The purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. PAR-19-194 (R21 for early stage research); PAR-19-193 (R01 for mature projects). Examples of Applications: (RO1, R21s).

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (Clinical Trial Optional)

These funding opportunities encourage Small Business Innovation Research (SBIR and STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the U.S. PAR-18-801 (R43/R44); PAR-18-802 (R41/42). For more information about these funding opportunities, download presentations from the NCI SBIR-CGH Joint Informational Webinar: SBIR-CGH Webinar1; SBIR-CGH Webinar2.

Note: Direct-to-Phase II is allowed for PAR-18-801

Dissemination and Implementation Research in Health (Clinical Trial Optional)

This funding opportunity encourages research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. PAR-19-274 (R01); PAR-19-275 (R21).

Dissemination and Implementation Research in Health (R03)

This funding opportunity encourages research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health practices for public health, clinical practice, and community settings.    

International Research Scientist Development Award (K01)

This funding opportunity supports intensive, mentored research career development for early stage investigators committed to a cancer research career. PAR-18-539 (Independent clinical trial not allowed). PAR-18-540 (Independent clinical trial required). For additional information, please visit Frequently Asked Questions for the International Research Scientist Development Award.

Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)

This funding opportunity supports U.S.- Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region, aligned with existing, publicly available U.S. datasets.

Cancer Moonshot℠ Funding Opportunities

These funding opportunities highlight research initiatives that align with the efforts of the Cancer Moonshot. Supported with existing or 21st Century Cures Act funds, featured announcements include open funding opportunities.

NIH Support for Conferences and Scientific Meetings (R13)

This funding opportunity supports high quality scientific conferences that are relevant to the NIH's mission and to the public health.

Previously Funded Initiatives

Learn more about CGH’s previously funded research grants and initiatives. Download list of CGH previously funded initiatives.

Training Opportunities

Learn more about training opportunities available to U.S. and international students, scientists, and health care professionals. 

Short-Term Scientist Exchange Program

The Short-Term Scientist Exchange Program at the Center for Global Health, National Cancer Institute, promotes collaborative research between researchers at the NCI and foreign cancer researchers.

NCI Summer Curriculum in Cancer Prevention Program

This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs and the All-Ireland Cancer Consortium (AICC).

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Funding for Global Research and Training was originally published by the National Cancer Institute.”